Page 23 - Astrazeneca

Oxford Covid-19 vaccine prompts immune response among adults: AstraZeneca

The Financial Times reported that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups. It cited two people familiar with the finding

Johnson & Johnson, AstraZeneca to resume trial for Covid-19 vaccine

Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill

AstraZeneca resumes US Covid vaccine trial; J&J prepares for same next week

(Reuters) - AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

AstraZeneca resumes US Covid-19 vaccine trial, optimism seen for J&J

AstraZeneca's US trial was paused on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial

AstraZeneca's volunteer who died didn't get Covid-19 vaccine: Report

Brazil's health authority Anvisa said it had been informed on Monday of the study volunteer's death and had received a partial report from an international committee assessing the trial's safety

AstraZeneca Covid-19 vaccine trial volunteer dies, did not receive dose

Oxford confirmed the plan to keep testing

World Coronavirus Dispatch: China finds infection risk in frozen food packs

Brazil's weekly cases lowest in 5 months, New Zealand has first community case in three weeks, Israel eases curbs and other pandemic-related news across the globe

Race for coronavirus cure hits reality as clinic complications mount

Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the presidential election on Nov. 3

AstraZeneca's Covid-19 antibody drug heads into final testing stage

The drug will be evaluated for its ability to prevent infections for up to a year in some people and as a preemptive medicine once patients have been exposed to the virus in others

Inhaled vaccines aim to target coronavirus at its point of invasion

Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections

US, AstraZeneca strike deal for Covid-19 antibody treatment touted by Trump

The US government has awarded $486 mn to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment

AstraZeneca could profit from Covid-19 vaccine as early as July: Report

AstraZeneca could start profiting from its Covid-19 vaccine as soon as July next year, the Financial Times reported

AstraZeneca's Japanese Covid-19 vaccine trial back up, US still paused

Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold, while discussions with US authorities continue

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan

Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now

World Coronavirus Dispatch: World economy to shrink 4.5% this yr, says OECD

The better view reflects the strong economic pickup in recent months and the vast injection of public resources

Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia

USFDA's Hahn plans significant work with AstraZeneca in Covid trial inquiry

The top US Food and Drug Administration official confirmed AstraZeneca's US Covid-19 vaccine trial is on hold

Some volunteers quit J&J Covid-19 trial in Spain after AstraZeneca scare

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

WHO praises AstraZeneca for pausing coronavirus vaccine global trial

A WHO official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety